Tag: WHO

68th WHO Regional Committee for Europe: Roadmap for access 2019–2023: Comprehensive support for access to medicines and vaccines
Infographic Good Manufacturing Practices - Convergence
IFPMA Statement @EB 142: Global strategy and plan of action on public health, innovation and intellectual property
The African Global Health Leaders Fellowship launched to support the future of health in Africa
IFPMA 2017 Interview Series: Experts take on 9th Asia Regulatory Conference
IFPMA 2017 Interview Series: WHO Dr Peter Beyer’s Take on Pat-INFORMED
IFPMA 2017 Interview Series: IFPMA DG Thomas Cueni’s Take on Pat-INFORMED
IFPMA Statement on Yellow Fever at 67th Session of the WHO Regional Committee for Africa
IFPMA Statement to New Essential Medicines List
IFPMA contribution to key global health discussions @WHA70 (22-31 May 2017)
WHO WHA 70 agenda item 15.2 Draft global action plan on the public health response to dementia
Visual capture of the panel discussion on Shortages
Handling of Post-approval Changes to Marketing Authorizations: Position Paper
IFPMA 2016 interview series on '@ preICDRA2016 - What to expect?'
Biopharma contributes to key global health discussions at WHA69
IFPMA & IFPW Supply chain session 2016 Global Health Forum - Video Highlights
IFPMA & IFPW Supply chain session 2016 Global Health Forum - long version
Improving the odds for early diagnosis of cervical cancer in Africa
IFPMA 2016 Geneva Pharma Forum on Biotherapeutics - Long version
2016 Geneva Pharma Forum Highlights on Biotherapeutics
WHO EB 136, Item 8.1, antimicrobial resistance
WHO EB 136, Item 5.1, Framework of engagement with non-State actors
IFPMA 2014 interview series on 'The R&D challenges in tackling Ebola'
IFPMA 2014 interview series “What’s at stake for biotherapeutic products?”
World Health Day 2014: Protect yourself from vector-borne diseases
Ten global health organizations united in a worldwide campaign to protect patients from fake medicines
Joint technical symposium by WHO, WIPO and WTO
IFPMA joins ITU and WHO in Be He@lthy, Be Mobile mHealth initiative to reduce the impact of non-communicable diseases (NCDs)
Research-based pharmaceutical industry pledges 14 billion treatments to help end nine neglected tropical diseases
Agenda item 6.11, "Elimination of schistosomiasis" at the 130th Executive Board of the World Health Organization

Other Tags

Access Access to antiretrovirals Access to Medicines Access to vaccines Africa AMR AMR Industry Alliance Anti-Counterfeit Antibiotics antimicrobial resistance Assembly Biosimilars Biotherapeutic Medicines Biotherapeutics Cancer Code of Practice collaboration Counterfeit Medicines Counterfeits Developing World Donations Economic footprint Efficacy Event Highlights Fake Medicines Fakes Fight the Fakes Flu Global Health harmonization Health Health Partnerships HIV/AIDS IFPMA IFPMA Assembly IFPMA Geneva Pharma Forum IFPMA Statement Immunization Incremental Innovation Influenza Influenza Vaccination Infographic Infographics Innovation Innovation ecosystem IP IVS Latin America Latin America Conference Malaria MDGs Medicines Mental and Neurological Disorders Millennium Development Goals NCD NCDs Neglected Tropical Diseases News Releases Non-Communicable Diseases NTDs Pandemic Influenza Pandemic preparedness partnership Partnerships Pharma Pharmacovigilance Position Paper Prevention PSI Publications Public Health Quality R&D Regulatory regulatory systems Regulatory System Strengthening Related Links Research Safety SDGs Seasonal Influenza Statements Supply chain Sustainable Development Goals Sustainable Innovation trade Treatments Tuberculosis UHC Universal Health Coverage Vaccine Vaccine Innovation Vaccines Vaccine Supply Value of Innovation Videos WHA WHO WIPO Women’s Cancers